External quality assessment program for qualitative and quantitative detection of hepatitis C virus RNA in diagnostic virology

Journal of Clinical Microbiology

Volumn 40, Issue 8, 2002, Pages 2973-2980

  Schirm, Jurjen ^a   Van Loon, Anton M ^a   Valentine Thon, Elizabeth ^a   Klapper, Paul E ^a   Reid, Jim ^a   Cleator, Graham M ^a  

^a Public Health Service of Groningen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; ASSAY; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LABORATORY DIAGNOSIS; MONITORING; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RNA ANALYSIS;

BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; HEPACIVIRUS; HEPATITIS C; HUMANS; LABORATORIES; POLYMERASE CHAIN REACTION; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0036701609     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.8.2973-2980.2002     Document Type: Article

References (19)

1. Damen, M., H. T. Cuypers, H. L. Zaaijer, H. W. Reesink, W. P. Schaasberg, W. H. Gerlich, H. G. Niesters, and P. N. Lelie. 1996. International collaborative study on the second EUROHEP HCV-RNA reference panel. J. Virol. Methods 58:175-185.
2. Jorgensen, P. A., and P. D. Neuwald. 2001. Standardized hepatitis C virus RNA panels for nucleic acid testing assays. J. Clin. Virol. 20:35-40.
3. Kawai, S., O. Yokusaka, T. Kanda, F. Imazeki, Y. Maru, and H. Saisho. 1999. Quantification of hepatitis C virus by TaqMan PCR: Comparison with HCV Amplicor monitor assay. J. Med. Virol. 58:121-126.
4. Lunel, F., M. Mariotti, P. Cresta, I. De La Croix, J.-M. Huraux, and J.-J. Lefrère. 1995. Comparative study of conventional and novel strategies for the detection of hepatitis C virus RNA in serum: Amplicor, branched-DNA, NASBA and in-house PCR. J. Virol. Methods 54:159-171.
5. Martinot-Peignoux, M., N. Boyer, M. Pouteau, C. Castelnau, N. Giuily, V. Duchatelle, A. Aupérin, C. Degott, J. D. Benhamou, S. Erlinger, and P. Mareellin. 1998. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. J. Hepatol. 29:214-223.
6. Martinot-Peignoux, M., P. Marcellin, M. Pouteau, C. Castelnau, N. Boyer, M. Poliquen, C. Degott, V. Descombes, V. Lebreton, V. Milotova, J. D. Benhamou, and S. Erlinger. 1995. Pretreatment serum HCV RNA levels and HCV genotype are the main and independent prognostic factors of sustained response to alpha interferon therapy in chronic hepatitis C. Hepatology 22:1050-1056.
7. Mellor, J., A. Hawkins, and P. Simmonds. 1999. Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J. Clin. Microbiol. 37:2525-2532.
8. Noordhoek, G. T., A. H. J. Kolk, G. Bjune, D. Catty, J. W. Dale, P. E. M. Fine, P. Godfrey-Faussett, S.-N. Cho, T. Shinnick, S. B. Svenson, S. Wilson, and J. D. A. van Embden. 1994. Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: A blind comparison study among seven laboratories. J. Clin. Microbiol. 32:277-284.
9. Quint, W. G. V., R. A. Heijtink J. Schirm, W. H. Gerlich, and B. Niesters. 1995. Reliability of methods for hepatitis B virus DNA detection. J. Clin. Microbiol. 33:225-228.
10. Roth, W. K., J. H. Lee, B. Ruster, and S. Zeuzem. 1996. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. J. Clin. Microbiol. 34:261-264.
11. Saldanha, J., N. Lelie, and A. Heath. 1999. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. W.H.O. Collaborative Study Group. Vox Sang. 76:149-158.
12. Schröter, M., B. Zöllner, P. Schäfer, R. Laufs, and H-H. Feucht. 2001. Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays. J. Clin. Microbiol. 39:765-768.
13. Schuurman, R., D. Descamps, G. J. Weverling, S. Kaye, J. Tijnagel, I. Williams, R. van Leeuwen, R. Tedder, C. A. B. Boucher, F. Brun-Vezinet, and C. Loveday. 1996. Multicenter comparison of three commercial methods for quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:3016-3022.
14. Tong, C. Y. W., R. C. Hollingsworth, H. Williams, W. L. Irving, and I. T. Gilmore. 1998. Effect of genotypes on quantification of hepatitis C virus (HCV) RNA in clinical samples with the Amplicor HCV. Monitor test and the Quantiplex HCV RNA 2.0 assay (bDNA). J. Med. Virol. 55:191-196.
15. Valentine-Thon E., A. M. van Loon, J. Schirm, J. Reid, P. E. Klapper, and G. M. Cleator. 2001. A European proficiency testing program for molecular detection and quantitation of hepatitis B virus DNA. J. Clin. Microbiol. 39:4407-4412.
16. Van Vliet, K., P. Muir, J. M. Echevarria, P. E. Klapper, G. M. Cleator, and A. M. van Loon. 2001. Multicenter proficiency testing of nucleic acid amplification methods for the detection of enteroviruses. J. Clin. Microbiol. 39:3390-3392.
17. Yen-Lieberman, B., D. Brambilla, B. Jackson, J. Bremer, R. Coombs, M. Cronin, S. Herman, D. Katzenstein, S. Leung, H. J. Lin, P. Palumbo, S. Rasheed, J. Todd, M. Vahey, and P. Reichelderfer. 1996. Evaluation of a quality assurance program for the quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group Virological Laboratories. J. Clin. Microbiol. 34:2695-2701.
18. Yu, M.-L., W.-L. Chuang, C.-Y. Dai, S.-C. Chen, Z.-Y. Lin, M.-Y. Hsieh, L.-Y. Wang, and W.-Y. Chang. 2000. Clinical evaluation of the automated Cobas Amplicor HCV monitor test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test. J. Clin. Microbiol. 38:2933-2939.
19. Zaaijer, H. L., H. T. M. Cuypers, H. W. Reesink, I. N. Winkel, G. Gerken, and P. N. Lelie. 1993. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 341:722-724.